Detalhe da pesquisa
1.
A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies.
Oncologist
; 25(6): 532-540, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943534
2.
Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS).
Pediatr Blood Cancer
; 66(12): e27987, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31502400
3.
Reporting of Racial and Ethnic Minority Representation in Early Phase Pediatric Oncology Clinical Trials.
Oncologist
; 27(8): e681-e682, 2022 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35791896
4.
Hypothalamic Glioma in a Patient With Sturge-Weber Syndrome.
J Pediatr Hematol Oncol
; 38(1): e10-2, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26422287
5.
Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression.
Hum Mol Genet
; 18(20): 3851-63, 2009 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19617633
6.
Chronic corticosterone exposure alters postsynaptic protein levels of PSD-95, NR1, and synaptopodin in the mouse brain.
Synapse
; 65(8): 763-70, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21190219
7.
Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies.
J Immunother Cancer
; 8(2)2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32883871
8.
Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease.
Am J Pathol
; 173(5): 1488-95, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18818379
9.
Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location.
PLoS One
; 6(3): e16886, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21390302